Effects of cefotaxime and desacetylcefotaxime upon Clostridium difficile proliferation and toxin production in a triple-stage chemostat model of the human gut

被引:73
作者
Freeman, J
O'Neill, FJ
Wilcox, MH [1 ]
机构
[1] Univ Leeds, Dept Microbiol, Leeds LS2 9JT, W Yorkshire, England
[2] Gen Infirm, Leeds LS2 9JT, W Yorkshire, England
关键词
Clostridium difficile; cefotaxime; desacetylcefotaxime; gut model; gut microflora;
D O I
10.1093/jac/dkg267
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Clostridium difficile is recognized as an important nosocomial pathogen. C. difficile infection (CDI) is thought to arise as a result of depletion of the normal gut flora by antimicrobial agents. Cefotaxime (CTX) is well-known for its propensity to cause CDI, but the reasons behind its particular predisposition to the disease remain unclear. Previous investigations have so far relied upon the hamster model of CDI or human volunteers. We have used a triple-stage chemostat model of the human gut to investigate the behaviour of C. difficile and components of the normal gut flora, in response to exposure to CTX alone, and in combination with its active metabolite desacetylcefotaxime (dCTX). C. difficile remained in a steady state during non-antibiotic exposed periods, with no detectable cytotoxin. During both antibiotic exposure regimens, proliferation of C. difficile and elevated cytotoxin levels were observed. Cessation of antibiotic instillation produced a reduction in cytotoxin levels and viable counts. Decreases in bacterial counts were observed in response to both antibiotic exposure regimens, notably for bifidobacteria and bacteroides. Numbers of bacteroides were profoundly affected by exposure to the CTX/dCTX combination, and this may indicate a possible role for bacteroides in colonization resistance. We believe that the gut model is a promising method for studying C. difficile pathogenesis in conditions analogous to the in vivo situation.
引用
收藏
页码:96 / 102
页数:7
相关论文
共 55 条
[1]   Comparative effects of cefadroxil and phenoxymethylpenicillin on the normal oropharyngeal and intestinal microflora [J].
Adamsson, I ;
Edlund, C ;
Sjostedt, S ;
Nord, CE .
INFECTION, 1997, 25 (03) :154-158
[3]   THE INFLUENCE OF SINGLE DOSE INTRAVENOUS ANTIBIOTICS ON FECAL FLORA AND EMERGENCE OF CLOSTRIDIUM-DIFFICILE [J].
AMBROSE, NS ;
JOHNSON, M ;
BURDON, DW ;
KEIGHLEY, MRB .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1985, 15 (03) :319-326
[4]   EFFECTS OF ANTIBIOTICS AND OTHER DRUGS ON TOXIN PRODUCTION IN CLOSTRIDIUM-DIFFICILE INVITRO AND INVIVO [J].
BARC, MC ;
DEPITRE, C ;
CORTHIER, G ;
COLLIGNON, A ;
SU, WJ ;
BOURLIOUX, P .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1992, 36 (06) :1332-1335
[5]  
BARTLETT JG, 1978, GASTROENTEROLOGY, V75, P778
[6]   CIPROFLOXACIN AND CLOSTRIDIUM-DIFFICILE INFECTION [J].
BATES, CJ ;
WILCOX, MH ;
SPENCER, RC ;
HARRIS, DM .
LANCET, 1990, 336 (8724) :1193-1193
[7]   IMPACT OF BIFIDOBACTERIUM-LONGUM ON HUMAN FECAL MICROFLORA [J].
BENNO, Y ;
MITSUOKA, T .
MICROBIOLOGY AND IMMUNOLOGY, 1992, 36 (07) :683-694
[8]   AN INVITRO MODEL OF COLONIZATION RESISTANCE TO CLOSTRIDIUM-DIFFICILE INFECTION [J].
BORRIELLO, SP ;
BARCLAY, FE .
JOURNAL OF MEDICAL MICROBIOLOGY, 1986, 21 (04) :299-309
[9]   MUCOSAL ASSOCIATION BY CLOSTRIDIUM-DIFFICILE IN THE HAMSTER GASTROINTESTINAL-TRACT [J].
BORRIELLO, SP ;
WELCH, AR ;
BARCLAY, FE ;
DAVIES, HA .
JOURNAL OF MEDICAL MICROBIOLOGY, 1988, 25 (03) :191-196
[10]   PROTECTION OF HAMSTERS AGAINST CLOSTRIDIUM-DIFFICILE ILEOCAECITIS BY PRIOR COLONIZATION WITH NON-PATHOGENIC STRAINS [J].
BORRIELLO, SP ;
BARCLAY, FE .
JOURNAL OF MEDICAL MICROBIOLOGY, 1985, 19 (03) :339-350